Does Rigel (RIGL) Have the Potential to Rally 40.88% as Wall Street Analysts Expect?

Shares of Rigel Pharmaceuticals (RIGL) have gained 24.6% over the past four weeks to close the last trading session at $21.65, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$30.50 indicates a potential upside of 40.9%.The average comprises six short-term price targets ranging from a low of $14 to a high of$57, with a standard deviation of $17.85. While the lowest estimate ind ...